Table 1 Patients’ characteristics
From: MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming
Patient | Age | Gender | Underlying liver disease | Etiology of fibrosis | Fibrosis score |
|---|---|---|---|---|---|
Group 1 | |||||
1 | 73 | M | HBV related HCC | HBV | F3 |
2 | 70 | M | HCV related HCC | HCV | F4 |
3 | 49 | M | Alcohol and metabolic cirrhosis (explanted liver) | Alcohol and NAFLD | F4 |
4 | 65 | M | Alcohol-related HCC (explanted liver) | Alcohol | F4 |
5 | 33 | M | HBV related HCC | HBV | F4 |
6 | 61 | M | HCV related HCC | HCV | F4 |
7 | 65 | F | Intrahepatic cholangiocarcinoma | NAFLD | F4 |
Group 2 | |||||
8 | 51 | M | Alcohol-related cirrhosis (explanted liver) | Alcohol | F4 |
9 | 68 | F | Metabolic cirrhosis (explanted liver) | NAFLD | F4 |
10 | 69 | M | Alcohol and metabolic-related HCC | Alcohol and NAFLD | F3/4 |
11 | 54 | F | Intrahepatic cholangiocarcinoma | NAFLD | F2 |
